Skip to main content
Premium Trial:

Request an Annual Quote

Diffinity Genomics Closes Series B Financing for Undisclosed Amount

Premium

Diffinity Genomics said this week that it has closed a Series B financing.

The privately held Rochester, NY-based company said it will use the funds primarily to commercialize new products, increase manufacturing capacity, and expand its sales team. However, a company spokesperson declined to disclose the financing amount.

The company's initial products, the Diffinity RapidTip and Diffinity RapidTip2, enable one-minute DNA purification from PCR solutions in a single step with a standard pipettor. Diffinity said that it is looking to add new RapidTip purification products to its portfolio for use in additional DNA purification applications.

New investors that contributed to the Series B round include Mass Med Angels and the Allyn Family Capital Fund.

Following the financing round, Diffinity appointed to its board of directors Donald Pogorzelski, former president of Genzyme Diagnostics and current vice chair of the New England Baptist Hospital's board of trustees; and Eric Allyn, an owner of medical device manufacturer Welch Allyn.

In September, Diffinity was awarded a pair of grants worth more than $200,000 from the National Human Genome Research Institute to further develop its nucleic acid purification technologies (PCR Insider, 9/15/2011).

Specifically, Lewis Rothberg, a professor of chemistry at the University of Rochester and chief technology officer at Diffinity, is principal investigator on the grants. Rothberg's lab developed the proprietary materials that Diffinity uses in its RapidTip. The company has a license to these technologies from the University of Rochester.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.